Tag: FDA
Vaccines and Operation Warp Speed
OWS Gets Credit for the Vaccine, But Did We Need It?
Are EUAs Deregulation or Regulatory Capture?
Why Emergency Use Authorizations Should Stay
FDA Continues to Meddle with Covid-19 Treatments
As the Opioid Epidemic Worsens, We Must Look at Free Market Solutions
New Alzheimer’s Drug Approval Could Change the FDA’s Approval Process for the Better
Ecstasy Nears FDA Approval to Treat Severe Post-Traumatic Stress Disorder
AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions
The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug
New COVID-19 Vaccines, Same Sluggish FDA
FDA Approves Blood Plasma as Covid-19 Treatment
Promising Alzheimer’s Drug on FDA Fast Track
To Make Drugs More Affordable, President Trump Should Focus on Price Competition
Keep Government Out of Developing a COVID-19 Vaccine
More Executive Orders Will Not Fix Healthcare
Cut Regulations and Get COVID-19 Drugs to Patients
Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus
The Mask Madness of Big Government
Coronacrisis and Leviathan
Favor Local Action to Combat the Coronavirus
FDA Acknowledges Coronavirus Is Causing More Drug Shortages
FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices
What Will the Coronavirus Reveal About Our Healthcare System?
Who Should Regulate Tobacco Products? Less Is More!
FDA Expands Ecstasy Access to Veterans with PTSD
Politicians Still Misunderstand High Insulin Prices

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org